These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8286217)

  • 21. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.
    Tsurusawa M; Niwa M; Katano N; Fujimoto T
    Cancer Res; 1988 Aug; 48(15):4288-93. PubMed ID: 3390825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex.
    O'Neill CF; Ormerod MG; Robertson D; Titley JC; Cumber-Walsweer Y; Kelland LR
    Br J Cancer; 1996 Oct; 74(7):1037-45. PubMed ID: 8855971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death.
    Shinomiya N; Shinomiya M; Wakiyama H; Katsura Y; Rokutanda M
    Exp Cell Res; 1994 Feb; 210(2):236-42. PubMed ID: 8299722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antitumor activity of cis-dichlorodiammineplatinum(II) and its effect on cell cycle progression].
    Takahashi K; Ebihara K; Honda Y; Nishikawa K; Kita M; Oomura M; Shibasaki C
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):624-31. PubMed ID: 6892196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric evaluation of the cell cycle perturbations induced by S12363, a new vinca alkaloid derivative.
    Leonce S; Anstett M; Combe-Perez V; Pierre A
    Anticancer Drugs; 1990 Dec; 1(2):179-83. PubMed ID: 2131051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular pharmacodynamics of ara-C and flowcytometric analysis of cell cycle progression in leukemia chemotherapy.
    Nakamura T; Takauji R; Kamiya K; Kawai Y; Iwasaki H; Tohyama K; Yamauchi T; Ueda T
    Leukemia; 1997 Apr; 11 Suppl 3():548-51. PubMed ID: 9209453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
    Roboz J; Jiang J; Holland JF; Bekesi JG
    Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR
    Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the plant cell inhibitor propachlor (alpha-chloro-N-isopropyl-acetanilide) on the cell cycle of L1210 cells as evaluated by flow cytometry.
    Zilkah S; Osband M; McCaffrey R; Shapiro H
    Life Sci; 1985 Jun; 36(22):2111-5. PubMed ID: 3999917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel nonclassical antifolate, 2-[N-(2´-Hydroxyethyl)amino]methyl-3H-quinazolin-4-one, with a potent antineoplastic activity toward leukemia cells.
    Cipak L
    Neoplasma; 2012; 59(6):641-9. PubMed ID: 22862178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
    Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
    Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to various kinase inhibitors.
    Somerville L; Cory JG
    Anticancer Res; 1999; 19(2A):1021-6. PubMed ID: 10368649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
    Han XJ; Shi SL; Wei YF; Jiang LP; Guo MY; Wu HL; Wan YY
    Oncol Rep; 2017 Aug; 38(2):985-992. PubMed ID: 28677814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of pulse and continuous intravenous infusion of cis-diamminedichloroplatinum on L1210 leukemia in vivo.
    Moran RE; Straus MJ
    Cancer Res; 1981 Dec; 41(12 Pt 1):4993-6. PubMed ID: 7198009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
    Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
    Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenolic compounds, sodium salicylate and related compounds, as inhibitors of tumor cell growth and inducers of apoptosis in mouse leukemia L1210 cells.
    Cory AH; Cory JG
    In Vivo; 2005; 19(1):31-5. PubMed ID: 15796154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model.
    Chang MC; Tsai ET; Wu JY; Liao HF; Chen YJ; Kuo CD
    Anticancer Drugs; 2015 Jun; 26(5):508-17. PubMed ID: 25588161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction and repair of DNA double-strand breaks using constant-field gel electrophoresis and apoptosis as predictive markers for sensitivity of cancer cells to cisplatin.
    Saleh EM; El-Awady RA; Anis N; El-Sharkawy N
    Biomed Pharmacother; 2012 Oct; 66(7):554-62. PubMed ID: 22939736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity of antitumor agents toward cultured murine leukemia L1210 cells under a serum-deprived apoptotic condition.
    Kasamatsu T; Kohda K; Kawazoe Y
    Anticancer Res; 1995; 15(6B):2597-600. PubMed ID: 8669831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.